PP13 and PAPP-A in the First and Second Trimesters: Predictive Factors for Preeclampsia?
- PMID: 22778981
- PMCID: PMC3385696
- DOI: 10.5402/2012/263871
PP13 and PAPP-A in the First and Second Trimesters: Predictive Factors for Preeclampsia?
Abstract
Background. Preeclampsia affects 5-6% of all pregnancies. Predictive factors of preeclampsia can be helpful in early diagnosis of this disease. In this study the predictive values of biochemical markers placenta protein 13 (PP13) and pregnancy-associated plasma protein A (PAPP-A) have been assessed in early diagnosis of preeclampsia. Methods. This case-control study was conducted on 1500 women who presented to a healthcare center of Sari, Iran, between 2010 and 2011. Blood samples were drawn in weeks 11-13 and 24-28 of pregnancy. Of them who developed preeclampsia were considered as case group. A control group consisted of similar women regarding mean age, body mass index (BMI), and pregnancy age. PAPP-A and PP13 serum levels were measured. Data were analyzed using proper statistical tests. Results. PAPP-A and PP13 serum levels were significantly lower in both the first and second trimesters in women who developed preeclampsia (P < 0.001). The cumulative value of all four variables with cut-off point of 238.5 has sensitivity, specificity of 91.0%, and undercurve surface of 0.968 which is the most diagnostic value for preeclampsia. Conclusion. It is possible to advantage measuring of PAPP-A and PP13 in the first and second trimesters especially their cumulative values in both trimesters for prediction of the incidence of preeclampsia.
Figures
Similar articles
-
First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.Taiwan J Obstet Gynecol. 2017 Jun;56(3):358-361. doi: 10.1016/j.tjog.2017.01.009. Taiwan J Obstet Gynecol. 2017. PMID: 28600048
-
[The value of maternal first and second trimester serum data of β-hCG, PAPP-A, AFP and uE3 in the prediction of preeclampsia].Zhonghua Fu Chan Ke Za Zhi. 2015 Feb;50(2):101-7. Zhonghua Fu Chan Ke Za Zhi. 2015. PMID: 25877605 Chinese.
-
Placental protein-13 (PP13) in combination with PAPP-A and free leptin index (fLI) in first trimester maternal serum screening for severe and early preeclampsia.Clin Chem Lab Med. 2017 Nov 27;56(1):65-74. doi: 10.1515/cclm-2017-0356. Clin Chem Lab Med. 2017. PMID: 28704180
-
Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis.Eur J Obstet Gynecol Reprod Biol. 2014 Nov;182:194-201. doi: 10.1016/j.ejogrb.2014.09.027. Epub 2014 Sep 22. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 25305662 Review.
-
Predictive Performance of Placental Protein 13 for Screening Preeclampsia in the First Trimester: A Systematic Review and Meta-Analysis.Front Med (Lausanne). 2021 Nov 19;8:756383. doi: 10.3389/fmed.2021.756383. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34869456 Free PMC article.
Cited by
-
Placental Protein 13 (PP13) - A Placental Immunoregulatory Galectin Protecting Pregnancy.Front Immunol. 2014 Aug 20;5:348. doi: 10.3389/fimmu.2014.00348. eCollection 2014. Front Immunol. 2014. PMID: 25191322 Free PMC article. Review.
-
Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia.J Pathol Transl Med. 2015 May;49(3):181-208. doi: 10.4132/jptm.2015.02.25. Epub 2015 May 15. J Pathol Transl Med. 2015. PMID: 26018511 Free PMC article. Review.
-
Placental protein 13: An important biological protein in preeclampsia.J Circ Biomark. 2018 Jul 15;7:1849454418786159. doi: 10.1177/1849454418786159. eCollection 2018 Jan-Dec. J Circ Biomark. 2018. PMID: 30023011 Free PMC article. Review.
-
Predictive Capabilities of Human Leukocyte Antigen-G and Galectin-13 Levels in the Amniotic Fluid and Maternal Blood for the Pregnancy Outcome.Medicina (Kaunas). 2024 Jan 1;60(1):85. doi: 10.3390/medicina60010085. Medicina (Kaunas). 2024. PMID: 38256346 Free PMC article.
-
Factors Associated with the Severity of Pregnancy-Related Hypertensive Disorder: Significance of Clinical, Laboratory, and Histopathological Features.Diagnostics (Basel). 2022 Sep 9;12(9):2188. doi: 10.3390/diagnostics12092188. Diagnostics (Basel). 2022. PMID: 36140589 Free PMC article.
References
-
- Heilmannl L, Seikmann U. Hemodynamic and hemorhological profiles in women with proteinuric hypertension og pregnancy and in pregnant controls. Archives of Gynecology and Obstetrics. 1998;246(3):159–168. - PubMed
-
- Chomian N. Investigation of during of activity phase and method delivering in primipar with preeclampsia. Raze Behzistan. 2003;10(4):6–9.
-
- Chaftez I, kuhnreich I, Smmar M, et al. First trimester Placental protein 13 screening for preeclampsia and intra uterin growth restriction. American Journal of Obstetrics and Gynecology. 2007;197(1):35–37. - PubMed
-
- Than NG, Pick E, Bellyei S, et al. Functional analyses of placental protein 13/galectin-13. European Journal of Biochemistry. 2004;271(6):1065–1078. - PubMed
-
- Nicolaides KH, Bindra R, Turan OM, et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound in Obstetrics and Gynecology. 2006;27(1):13–17. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous